2019年度恶性淋巴瘤主要进展——遵循循证医学证据,持续推进淋巴瘤规范化诊疗

    Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma

    /

    返回文章
    返回